Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 31, 2018 - Issue 3
Submit an article Journal homepage
47
Views
1
CrossRef citations to date
0
Altmetric
Case Studies

Cutaneous toxicity of oral low-dose methotrexate

Priyanka JalandharaDivision of Research, PPG Healthcare, Fort Worth, TexasCorrespondence[email protected]
, MD &
Gurjit KaeleyDivision of Rheumatology, Department of Medicine, University of Florida, Jacksonville, Florida
, MD
Pages 364-366 | Received 21 Jan 2018, Accepted 22 Mar 2018, Published online: 22 May 2018

  • Cronstein BN. Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev. 2005;57:163–172. doi:10.1124/pr.57.2.3. PMID:15914465.
  • Varela CR, McNamara J, Antaya RJ. Acral erythema with oral methotrexate in a child. Pediatr Dermatol. 2007;24:541–546. doi:10.1111/j.1525-1470.2007.00513.x. PMID:17958806.
  • Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol. 1991;24:457–461. PMID:2061446.
  • Lokich JJ, Moore C. Chemotherapy-associated palmar–plantar erythrodysesthesia syndrome. Ann Intern Med. 1984;101:798–799. PMID:6497196.
  • Vukelja SJ, Lombardo FA, James WD, Weiss RB. Pyridoxine for the palmar–plantar erythrodysesthesia syndrome. Ann Intern Med. 1989;111:688–689.
  • Tsuruta D, Mochida K, Hamada T, et al. Chemotherapy-induced acral erythema: Report of a case and immunohistochemical findings. Clin Exp Dermatol. 2000;25:386–388. PMID:11012591.
  • Ogawa H, Sugiyama H, Tani Y, et al. High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen. Leuk Lymphoma. 1998;29:171–177. doi:10.3109/10428199809058392. PMID:9638986.
  • Chang JC. Acute bullous dermatosis and onycholysis due to high-dose methotrexate and leucovorin calcium. Arch Dermatol. 1987;123:990–992. PMID:3307638.
  • Doyle LA, Berg C, Bottino G, Chabner B. Erythema and desquamation after high-dose methotrexate. Ann Intern Med. 1983;98(Pt 1):611–612. PMID:6601925.
  • Feizy V, Namazi MR, Barikbin B, Ehsani A. Methotrexate-induced acral erythema with bullous reaction. Dermatol Online J. 2003;9:14. PMID:12639472.
  • Hellier I, Bessis D, Sotto A, Margueritte G, Guilhou JJ. High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol. 1996;132:590–591. PMID:8624164.
  • Millot F, Auriol F, Brecheteau P, Guilhot F. Acral erythema in children receiving high-dose methotrexate. Pediatr Dermatol. 1999;16:398–400. PMID:10571844.
  • Morrell DS, Challgren E, Eapen M, Esterly NB. Bullous acral erythema secondary to high-dose methotrexate. J Pediatr Hematol Oncol. 2002;24:240. PMID:11990316.
  • Postovsky S, Ben Arush MW. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma. Pediatr Hematol Oncol. 2005;22:167–173. doi:10.1080/08880010590907320. PMID:15805003.
  • Werchniak AE, Chaffee S, Dinulos JG. Methotrexate-induced bullous acral erythema in a child. J Am Acad Dermatol. 2005;52(Suppl 1):S93–S95. doi:10.1016/j.jaad.2004.11.065. PMID:15858519.
  • Ikeda H, Kawano H, Kitaura T, Kimura A, Kihira K. Acral erythema associated with high-dose methotrexate infusion. Ann Pharmacother. 1999;33:646. PMID:10369634.
  • Kuruvila S, Dalal M, Sivanesan B. Bullous variant of acral erythema due to methotrexate. Indian J Dermatol Venereol Leprol. 2006;72:440–442. PMID:17179620.
  • Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia (“hand–foot”) syndrome. Incidence, recognition and management. Am J Clin Dermatol. 2000;1:225–234. PMID:11702367.
  • Cordonnier C, Roujeau JC, Vernant JP, Matheron S, Ganem G. Cancer chemotherapy and acral erythema. Ann Intern Med. 1982;97:783–783.
  • Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease. Am J Med Sci. 2006;332:156–158. PMID:16969149.
  • Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum. 2004;34:465–483.
  • Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 1996;39:272–276. PMID:8849378.
  • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 1996;39:713–722. PMID:8639167.
  • Bezabeh S, Mackey AC, Kluetz P, Jappar D, Korvick J. Accumulating evidence for a drug–drug interaction between methotrexate and proton pump inhibitors. Oncologist. 2012;17:550–554. doi:10.1634/theoncologist.2011-0431. PMID:22477728.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.